Research

Scientific illustration showing amphotericin B disrupting an Aspergillus fungal cell membrane during research into antifungal resistance.

Amphotericin B resistance in Aspergillus: protecting an important treatment for the future

Clinician reviewing CT scans showing chronic pulmonary aspergillosis, mucus plugging and a lung cavity

Aspergillosis Weekly Research Update: New Clues About Diagnosis, Treatment and Resistance

Illustration of lungs, airway cells, DNA and Aspergillus spores representing Manchester research into genetic susceptibility to aspergillosis.

Can We Predict Who Will Develop Aspergillosis? Genetics, Epigenetics and the Search for Individual Risk

Illustration of Aspergillus fumigatus spores interacting with the bronchial airway lining beside a DNA strand representing the ZNF77 gene variant.

Lung Colonisation by Aspergillus fumigatus Is Influenced by a ZNF77 Gene Variant

Aspergillosis Research Update: Corticosteroid Risks, Azole Resistance and Immune Recovery

Illustration of lungs, Aspergillus and an intravenous infusion representing rezafungin research for chronic pulmonary aspergillosis

Rezafungin for chronic pulmonary aspergillosis: encouraging early evidence while clinical trial continues

Illustration of lungs, a DNA strand and Aspergillus spores representing research into CFTR gene variants and ABPA

Carriers of cystic fibrosis may be at greater risk for allergic bronchopulmonary aspergillosis

Aspergillosis research update infographic summarising July 2026 studies on invasive aspergillosis, isavuconazole, macrophages and tuberculosis.

Aspergillosis Research Update: ICU Infections, Immune Defences and Antifungal Treatment

Infographic summarising the July 2026 weekly aspergillosis research update, highlighting new COPD diagnostic criteria for invasive pulmonary aspergillosis, chronic pulmonary aspergillosis serology, ICU galactomannan testing, environmental prevention of fungal disease, and other key research developments.

Weekly Aspergillosis Research Update: COPD IPA Criteria, CPA Serology, ICU Galactomannan and Environmental Prevention

Illustration summarising new research showing allergic bronchopulmonary aspergillosis (ABPA) and Aspergillus sensitisation may be more common in people with chronic obstructive pulmonary disease (COPD).

Weekly Aspergillosis Research Update: June 29